Sanofi delivers 2018 business EPS growth of 5.1% at CER
Fourth quarter and full year 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
- Recorded audio webcast
- Download the audio mp3 file
- Presentation
- Clinical trials appendix
- Press release – February 7, 2019: Sanofi delivers 2018 business EPS growth of 5.1% at CER
- Q4 and full year 2018 income statements, cash flow statements, balance sheet
- Q4 and full year 2018 net sales by GBU, franchise, geographic region and product
- Download infographic
- 2018 sales reflecting the 2019 GBU structure
